Orexo AB Sustainability Reports
Orexo AB is a specialty pharmaceutical company that develops improved drugs and treatment solutions utilizing proprietary drug delivery technologies. The company primarily addresses medical needs related to opioid use disorder and related therapeutic areas.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300LJ5CCWDPTK9Z08
FIGI: BBG001SPP3S7
17 reports from 2015 to 2025
